Patent News Round Up: Supreme Court Asked To Review Plavix Patent; New Director May Scrap PTO Rules; Patenting Of Natural Process Debated
Executive Summary
Apotex really wants to get a generic version of Plavix (clopidogrel) on the market before the patent on the drug expires in 2011. Defeated in its efforts to get the patent ruled invalid, the company has asked the Supreme Court to take up the case
You may also be interested in...
PTO Rescinds Regs Reviled By Pharma, But Rule-Making Battle Continues
While biotech and pharma companies continue to face myriad patent battles they have one less worry now that the U.S. Patent and Trademark Office has dropped its controversial rules to limit the number of patent claims and continuation filings an applicant may submit
PTO Rescinds Regs Reviled By Pharma, But Rule-Making Battle Continues
While biotech and pharma companies continue to face myriad patent battles they have one less worry now that the U.S. Patent and Trademark Office has dropped its controversial rules to limit the number of patent claims and continuation filings an applicant may submit
Patent Rule On Continuations Is Invalid; Three Others May Still Bite Pharma
The drug industry won a partial victory in its battle with the U.S. Patent and Trademark Office over rules to limit certain patent filings